Speaker illustration

undefined undefined undefined

The association between the response of lipid-lowering agents and monogenic variants of familiar hypercholesteremia in Taiwan

Event: ESC Congress 2025

Topic: Drug therapy

Session: Drug therapy (1)

Thumbnail

Ranolazine ameliorates palmitic acid-induced insulin resistance in HL-1 cardiomyocytes by Ca2+/ CaMKII modulation: an in vitro investigation and population-based cohort study

Event: ESC Congress 2025

Topic: Cardiovascular Pharmacotherapy

Session: Cardiotoxicity and protection: from bench to bedside

Thumbnail

The interaction of bone morphogenetic protein receptor type 2 and pentraxin 3 on inflammation and fibrosis: implications for pulmonary hypertension

Event: ESC Congress 2025

Topic: Pulmonary Hypertension

Session: Pathobiology of pulmonary hypertension

Thumbnail

Highlights from FINEARTS-HF and FINE-HEART: the role of finerenone in heart failure

Event: ESC Congress 2024

Topic: European Society of Cardiology

Session: Daily Highlights by the Taiwan Society of Cardiology

Thumbnail

Activation of fibroblast growth factor 21 by Canagliflozin reduces high-fat diet associated obesity-related cardiac injury: a translational study from bench to bedside

Event: ESC Congress 2024

Topic: Obesity

Session: Nutrition and heart disease

Thumbnail

Rho kinase pathway is crucial for platelet activation in the culprit coronary artery microenvironment during an acute coronary syndrome event: a clinical and platelet ribosome profile sequencing study

Event: ESC Congress 2017

Topic: Platelets

Session: Cardiovascular cell biology

Thumbnail

CCAAT/enhancer binding protein delta contributes to an earlier phase of pro-inflammatory response in doxorubicin related cardiomyopathy

Event: ESC Congress 2016

Topic: Cardiotoxicity of drugs

Session: Cancer and cardiotoxicity: from bench to bedside

Thumbnail

ESC 365 is supported by